The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mitochondrial dysfunction in heart failure
Open accessAbstract
Heart failure (HF) is a complex chronic clinical syndrome. Energy deficit is considered to be a key contributor to the development of both cardiac and skeletal myopathy. In HF, several components of cardiac and skeletal muscle bioenergetics are altered, such as oxygen availability, substrate oxidation, mitochondrial ATP production, and ATP transfer to the contractile apparatus via the creatine kinase shuttle. This review focuses on alterations in mitochondrial biogenesis and respirasome organization, substrate oxidation coupled with ATP synthesis in the context of their contribution to the chronic energy deficit, and mechanical dysfunction of the cardiac and skeletal muscle in HF. We conclude that HF is associated with decreased mitochondrial biogenesis and function in both heart and skeletal muscle, supporting the concept of a systemic mitochondrial cytopathy. The sites of mitochondrial defects are located within the electron transport and phosphorylation apparatus and differ with the etiology and progression of HF in the two mitochondrial populations (subsarcolemmal and interfibrillar) of cardiac and skeletal muscle. The roles of adrenergic stimulation, the renin–angiotensin system, and cytokines are evaluated as factors responsible for the systemic energy deficit. We propose a cyclic AMP-mediated mechanism by which increased adrenergic stimulation contributes to the mitochondrial dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-376 · Cited by 1,789 · cited 2×
“Mitochondrial proliferation also is found in murine models of cardiomyopathies associated with ablation of either the adenine nucleotide translocase 1 [41], frataxin [42], Mn-SOD [43], or mtTFA”
BackgroundHjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Bozkurt, B., Kribbs, S. B., Clubb, F. J., Michael, L. H., Didenko, V. V., Hornsby, P. J., Seta, Y., Oral, H., Spinale, F. G., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1382 · Cited by 821 · cited 1×
“to the left ventricle remodeling and progression to HF [150] as well as to mitochondrial dysfunction.”
BackgroundThe biosynthesis and functional role of cardiolipin
Schlame, M., Rua, D., & Greenberg, M. L. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00005-9 · Cited by 810 · cited 1×
“ETC individual complex activities require the integrity of protein subunits, their assembly in active complexes, and the lipid microenvironment of the inner membrane enriched in cardiolipin [99–109].”
BackgroundNADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738 · cited 1×
“Mitochondrial proliferation also is found in murine models of cardiomyopathies associated with ablation of either the adenine nucleotide translocase 1 [41], frataxin [42], Mn-SOD [43], or mtTFA”
BackgroundDai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.232306 · Cited by 527
Lai, L., Leone, T. C., Zechner, C., Schaeffer, P. J., Kelly, S. M., Flanagan, D. P., Medeiros, D. M., Kovacs, A., & Kelly, D. P. (2008) · Genes & Development · doi:10.1101/gad.1661708 · Cited by 326 · cited 1×
“PGC-1a controls optimal mitochondrial content, and its amount is directly correlated with mitochondrial density in both cardiac and skeletal muscle [20, 21].”
BackgroundPhospholipid-Cytochrome c Interaction
Tuominen, E. K. J., Wallace, C. J. A., & Kinnunen, P. K. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200056200 · Cited by 309
Threshold Effect and Tissue Specificity
Rossignol, R., Malgat, M., Mazat, J.-P., & Letellier, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33426 · Cited by 288
Functional binding of cardiolipin to cytochromec oxidase
Robinson, N. C. (1993) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762857 · Cited by 265 · cited 1×
“ETC individual complex activities require the integrity of protein subunits, their assembly in active complexes, and the lipid microenvironment of the inner membrane enriched in cardiolipin [99–109].”
BackgroundKimura, S., Zhang, G.-X., Nishiyama, A., Shokoji, T., Yao, L., Fan, Y.-Y., Rahman, M., Suzuki, T., Maeta, H., & Abe, Y. (2005) · Hypertension · doi:10.1161/01.hyp.0000163462.98381.7f · Cited by 264
Hansson, A., Hance, N., Dufour, E., Rantanen, A., Hultenby, K., Clayton, D. A., Wibom, R., & Larsson, N.-G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308710100 · Cited by 220 · cited 1×
“Notably, the increased mitochondrial mass in the myocardium of mtTFA knockout mice is accompanied by a decrease in mtDNA replication and transcription, as well as impaired mitochondrial electron transport chain (ETC) [44].”
BackgroundMiura, S., Kawanaka, K., Kai, Y., Tamura, M., Goto, M., Shiuchi, T., Minokoshi, Y., & Ezaki, O. (2007) · Endocrinology · doi:10.1210/en.2006-1646 · Cited by 183
Toledo, F. G. S., Watkins, S., & Kelley, D. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0002 · Cited by 126 · cited 1×
“For example, physical activity complemented with weight loss is associated with an increased number and volume of skeletal IFM in obese human subjects [23].”
BackgroundTaub, P. R., Ramirez‐Sanchez, I., Ciaraldi, T. P., Perkins, G., Murphy, A. N., Naviaux, R., Hogan, M., Maisel, A. S., Henry, R. R., Ceballos, G., et al. (2012) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00357.x · Cited by 122 · cited 1×
“In contrast, HF is associated with an overall disarray in mitochondrial structure [18] and decrease in cristae surface [19] sug-”
BackgroundThe Mitochondrial Phenotype of Peripheral Muscle in Chronic Obstructive Pulmonary Disease
Picard, M., Godin, R., Sinnreich, M., Baril, J., Bourbeau, J., Perrault, H., Taivassalo, T., & Burelle, Y. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1005oc · Cited by 95 · cited 1×
“In contrast, decreased mitochondrial density is reported in vastus lateralis in patients with COPD [38], whereas the mitochondrial respiratory function is preserved [39].”
BackgroundRibera, F., N'Guessan, B., Zoll, J., Fortin, D., Serrurier, B., Mettauer, B., Bigard, X., Ventura-Clapier, R., & Lampert, E. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-519oc · Cited by 91 · cited 1×
“The increased work of breathing in COPD is considered responsible for the increased mitochondrial density and respiratory properties in the diaphragm that are correlated with the index of obstruction [37].”
Background
Cited by
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 827
Mitochondrial function as a therapeutic target in heart failure
Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., Voors, A. A., et al. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.203 · Cited by 803
Aimo, A., Castiglione, V., Borrelli, C., Saccaro, L. F., Franzini, M., Masi, S., Emdin, M., & Giannoni, A. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319870344 · Cited by 343
Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association
Taegtmeyer, H., Young, M. E., Lopaschuk, G. D., Abel, E. D., Brunengraber, H., Darley-Usmar, V., Des Rosiers, C., Gerszten, R., Glatz, J. F., Griffin, J. L., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000097 · Cited by 286
Metadata
- Authors
- Rosca, M. G., & Hoppel, C. L.
- Venue
- Heart Failure Reviews
- Published
- 2012-09-05
- Volume
- 18
- Issue
- 5
- Pages
- 607-622
- ISSN
- 1382-4147 (ISSN-L)
- 1573-7322
- OpenAlex
- W2024799186
- Cited by
- 247
- References
- 20
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.